Does Rallies show 13F holders for PGEN?

Yes. Rallies tracks hedge fund and 13F ownership data for PGEN, including fund names, share counts, latest tracked quarter, and position changes when available.

Is PGEN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PGEN. It does not provide personalized investment advice.

PGEN (Precigen, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Precigen, Inc. Common Stock (PGEN) is a publicly traded Healthcare sector company. As of May 21, 2026, PGEN trades at $4.34 with a market cap of $1.45B and a P/E ratio of -3.12. PGEN moved +2.40% today. Year to date, PGEN is +2.15%; over the trailing twelve months it is +202.84%. Its 52-week range spans $0.65 to $5.47. Analyst consensus is buy with an average price target of $11.00. Rallies surfaces PGEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns PGEN stock?

Hedge funds tracked by Rallies that own PGEN include Panagora Asset, Farallon Capital, and Polen Capital. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Precigen, Inc. Common Stock.

PGEN Key Metrics

Key financial metrics for PGEN
Metric	Value
Price	$4.34
Market Cap	$1.45B
P/E Ratio	-3.12
EPS	$-1.37
Dividend Yield	0.00%
52-Week High	$5.47
52-Week Low	$0.65
Volume	383
Avg Volume	0
Revenue (TTM)	$9.68M
Net Income	$-250.64M
Gross Margin	0.00%

Top Hedge Funds Holding PGEN

Panagora Asset holds 155.59K shares of PGEN, changed -0.40% as of Jun 30, 2024.
Farallon Capital holds 50.00K shares of PGEN, changed +0.00% as of Mar 31, 2026.
Polen Capital holds 42.09K shares of PGEN, changed +0.00% as of Dec 31, 2025.

Latest PGEN News

Precigen Reports $21.6M Q1 PAPZIMEOS Revenue and $0.02 EPS Loss — May 13, 2026
Precigen Expects Q1 Revenue Above $18M After $3.4M Q4 PAPZIMEOS Sales — Apr 7, 2026
Precigen to Launch Papziemos After Early Approval, Shares Up 89.8% — Mar 5, 2026

Recent PGEN Insider Trades

KIRK RANDAL J sold 1.11M (~$3.66M) on Mar 30, 2026.
KIRK RANDAL J sold 50.80K (~$167.63K) on Mar 30, 2026.
KIRK RANDAL J sold 370.85K (~$1.22M) on Mar 30, 2026.

PGEN Analyst Consensus

2 analysts cover PGEN: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $11.00.

Common questions about PGEN

Who owns PGEN stock?: Hedge funds tracked by Rallies that own PGEN include Panagora Asset, Farallon Capital, and Polen Capital. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Precigen, Inc. Common Stock.
Does Rallies show 13F holders for PGEN?: Yes. Rallies tracks hedge fund and 13F ownership data for PGEN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PGEN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PGEN. It does not provide personalized investment advice.